Publications


2018

Inherited factors contribute to an inverse association between preeclampsia and breast cancer.

Yang H, He W, Eriksson M, Li J, Holowko N, Chiesa F, Hall P, Czene K.


Breast Cancer Res
201801
https://www.ncbi.nlm.nih.gov/pubmed/29361985

2017

Breast Tissue Organisation and its Association with Breast Cancer Risk.

Ali MA, Czene K, Eriksson L, Hall P, Humphreys K.


Breast Cancer Res
201712
https://pubmed.ncbi.nlm.nih.gov/28877713/

Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women.

Li J, Eriksson M, He W, Hall P, Czene K.


Sci Rep
201712
https://pubmed.ncbi.nlm.nih.gov/29208999/

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).

Gabrielson M, Eriksson M, Hammarström M, Borgquist S, Leifland K, Czene K, Hall P.


Int J Epidemiol
201712
https://pubmed.ncbi.nlm.nih.gov/28180256/

PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1.

Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, et al.


Oncotarget
201711
https://pubmed.ncbi.nlm.nih.gov/29262523/

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, Wildiers H, et al.


Breast Cancer Res
201711
https://pubmed.ncbi.nlm.nih.gov/29116004/

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.

Andersson TM, Crowther MJ, Czene K, Hall P, Humphreys K.


Am J Epidemiol
201711
https://pubmed.ncbi.nlm.nih.gov/28633324/

Association analysis identifies 65 new breast cancer risk loci.

Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, et al.


Nature
201710
https://pubmed.ncbi.nlm.nih.gov/29059683/

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, et al.


Nat Genet
201710
https://pubmed.ncbi.nlm.nih.gov/29058716/

Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.

He W, Smedby KE, Fang F, Olsson H, Margolin S, Hall P, Czene K.


J Natl Cancer Inst
201710
https://pubmed.ncbi.nlm.nih.gov/28423398/

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching PA, Beckmann MW, Gago-Dominguez M, et al.


Int J Cancer
201708
https://pubmed.ncbi.nlm.nih.gov/28670784/

Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study.

Yang H, Brand JS, Li J, Ludvigsson JF, Ugalde-Morales E, Chiesa F, Hall P, Czene K.


BMC Med
201708
https://pubmed.ncbi.nlm.nih.gov/28797265/

Common shared genetic variation behind decreased risk of breast cancer in celiac disease.

Ugalde-Morales E, Li J, Humphreys K, Ludvigsson JF, Yang H, Hall P, Czene K.


Sci Rep
201707
https://pubmed.ncbi.nlm.nih.gov/28725034/

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity.

Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, Hall P, Czene K.


Cancer Res
201705
https://pubmed.ncbi.nlm.nih.gov/28512241/

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, et al.


Nat Genet
201704
https://pubmed.ncbi.nlm.nih.gov/28436984/

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al.


Oncotarget
201703
https://pubmed.ncbi.nlm.nih.gov/28179588/

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calléja FMGR, Meeks H, et al.


Cancer Res
201703
https://pubmed.ncbi.nlm.nih.gov/28283652/

Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.

Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K.


Int J Cancer
201702
https://pubmed.ncbi.nlm.nih.gov/27859142/

A clinical model for identifying the short-term risk of breast cancer.

Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P.


Breast Cancer Res
201701
https://pubmed.ncbi.nlm.nih.gov/28288659/

2016

Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry.

Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, et al.


Breast Cancer Res
201612
https://pubmed.ncbi.nlm.nih.gov/27931260/